We demonstrated that cystatin F expression was specifically elevated in the monocytes of sporadic AD patients and that in vivo, human cystatin F aggravated Aβ deposition in the brain and cognitive impairment in APP/PS1 mice. Here, APP is linked to Alzheimer disease.